Klein, Saul
At least 3 active companies
These details are public data from the Companies House register.
- Nationality
- British
- Country of residence
- Israel
Appointments 3 current
Not a complete list. See all appointments on Companies House
Director · Appointed 14 August 2019
Active
Net assets £3.8M, 2022 accounts (newer filed) · Incorporated 2019
Director · Appointed 8 August 2025
Active
Net assets £364.8k, 2025 accounts (newer filed) · Incorporated 2020
Former appointments (9)
Director · Appointed 8 February 2023 · Resigned 6 June 2025
Company active
Director · Appointed 21 April 2016 · Resigned 12 March 2026
Company active
Director · Appointed 17 September 2015 · Resigned 6 December 2018
Company active
Director · Appointed 27 May 2015 · Resigned 25 April 2022
Company active
Director · Appointed 30 September 2013 · Resigned 16 April 2020
Company active
LLP Designated Member · Appointed 29 June 2009 · Resigned 30 June 2015
Company active
Director · Appointed 12 May 2009 · Resigned 17 March 2015
Company active
Director · Appointed 1 April 2008 · Resigned 20 June 2014
Company active
Director · Appointed 28 June 2007 · Resigned 20 December 2007
Company active
Works with
Officers serving alongside Klein, Saul
Aparicio, Samuel, Dr
Director at Genome Therapeutics Ltd
Cui, Xiangmin, Dr
Director at Genome Therapeutics Ltd
Glasheen, James Walter, Dr
Director at Genome Therapeutics Ltd
Mchugh, Dan
Director at Genome Therapeutics Ltd